<DOC>
	<DOCNO>NCT01408589</DOCNO>
	<brief_summary>This two-stage study examine effect 5 day course atomoxetine ( placebo , 40 , 60 80 mg/day ; Strattera ) ( selective NE transporter ( NET ) inhibitor ) alcohol-elicited crave sensitivity alcohol . The novelty study atomoxetine fact target NET , neither heretofore examine context alcohol dependence . It hopeful pilot study , 86 total individual , provide PI sufficient preliminary data submit subsequent R01 application study atomoxetine involvement specific single nucleotide polymorphism within NET gene alcohol-related phenotype alcohol dependent non-dependent population . The long-term objective research develop efficacious treatment intervention alcohol abuse dependence . Hypothesis 1 : It hypothesize subject receive 40 , 60 80 mg/day atomoxetine 5 day demonstrate significantly less alcohol-elicited craving subject receive placebo . Hypothesis 2 : It hypothesize subject receive 40 , 60 80 mg/day atomoxetine 5 day less sensitive acute effect alcohol ( subjective intoxication ) subject receive placebo .</brief_summary>
	<brief_title>A Dose Response Effect Atomoxetine Acute Effects Alcohol</brief_title>
	<detailed_description />
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Inclusion Criterion : 1 . Males females age 21 35 , verify upon presentation valid driver 's license ; 2 . Must drink alcohol least twice week minimum 3 drink per occasion ( 2 woman ) ; 3 . Must score 8 high Alcohol Use Disorders Identification Test ( AUDIT ; Babor et al. , 1992 ) . The AUDIT screening instrument use identify person whose alcohol consumption characterize moderate heavy drinking ; 4 . No history alcohol treatment desire treatment ; 5 . Not currently take medication contraindicate concurrent use alcohol ; 6 . Female subject must pregnant , indicated pregnancy test conduct immediately prior dispense medication . Exclusion Criterion : Subjects hypertension , tachycardia , cardiovascular disease , hepatic renal impairment , pregnant currently use MAO inhibitor , Albuterol pressor agent exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>alcohol</keyword>
	<keyword>crave</keyword>
	<keyword>mood</keyword>
	<keyword>optimum dose atomoxetine</keyword>
</DOC>